BAMVBrookstone Value Stock ETF

Grow my money2y track recordRanked #2,175 of 2,960 in this goal

Seeks to provide capital appreciation.

By Brookstone Asset Management · Launched 2023

Annual Cost

0.91%

#4,563 of 5,562 · expensive

Fund Size

$102M

#2,919 of 5,562 · mid-size

Return (1Y)Goal

+15.5%

Track Record

2 years

#3,193 of 5,562 · seasoned

Performance

Total-return NAV · USD

Growth of $10,000

$11,595+15.9%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Multi cap

Strategy

Active selection

Factor

Value

What it actually holds

By weight

Concentration

Top 10 holdings = 38.3% of fund✓ well diversified

Merck & Co., Inc

4.1%

Advanced Micro Devices Inc.

4.1%

Thermo Fisher Scientific Inc

4.1%

Johnson & Johnson

4.0%

Lennar Corp.

3.8%

Bank of America Corp.

3.7%

Bristol-Myers Squibb Company

3.6%

QUALCOMM Inc.

3.6%

General Dynamics Corporation

3.6%

Fortive Corporation

3.6%

Asset allocation

Stocks

96.3%

Cash

3.7%

By sector

Financial Services

28.3%

Technology

26.0%

Industrials

10.4%

Healthcare

9.8%

Communication

8.7%

Energy

5.9%

Basic Materials

4.9%

Real Estate

2.8%

Other

3.2%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

11.9%Moderate

Year-on-year price swings

Max drawdown

-14.6%Mild

Worst peak-to-trough loss

Sharpe (3Y)

Unavailable

Needs 3+ years of history

Sortino (3Y)

Not yet

Needs 3+ years of history

Where to buy

Listing

Exchange: Cboe BZX

Full fund details

Objective: Seeks to provide capital appreciation.
Strategy: Actively manages a portfolio primarily invested in publicly traded U.S. equity stocks, focusing on mid-cap companies or larger with a minimum market capitalization of $2 billion. The adviser seeks high-quality value-oriented stocks across various sectors.
Inception date: September 26, 2023
Fund family: Brookstone Asset Management